Skip to content
Screener

Danaher DHR Q1 2026 earnings

Reported April 21, 2026 · Before market open

Revenue$6.0BMiss by $30.6M
EPS$2.06Beat by $0.12
Revenue estimate$6.0B
EPS estimate$1.94

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$6.6B
EPS estimate$1.91

Financials

Q1 2026

Income statement

See full
Revenue$6.0B+3.7%
Gross profit$3.6B+2.3%
Operating income$1.3B+5.5%
Net income$1.0B+7.9%
EPS (diluted)$1.45+9.8%

Balance sheet

See full
Cash & equivalents$5.7B+186%
Total debt$19.7B+12.0%
Total equity$52.9B+4.1%
Total assets$83.5B+5.6%

Cash flow

See full
Operating cash flow$1.3B+1.8%
CapEx$237.0M-3.3%
Free cash flow$1.1B+2.9%

Valuation & ratios

Valuation

as of 03/27/26
See full
Market cap$134.18B-8.5%
Enterprise value$148.16B-8.7%
P/E36.4×-2.6×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.9%-0.8pp
Operating margin19.2%-1.0pp
Net margin14.9%-0.9pp
FCF margin21.4%+0.8pp

Returns & leverage

See full
Return on equity7.1%-0.1pp
Debt / equity0.4×0.0×
Current ratio1.9×+0.4×

Segments

By geography

See full
North America$2.5B-4.0%
High-growth markets$1.6B+5.7%
Western Europe$1.6B+16.4%
Other developed markets$284.0M+2.2%

By product

See full
Recurring revenue$5.0B+4.5%
Nonrecurring revenue$920.0M-0.5%

By segment

See full
Biotechnology$1.8B+11.5%

FAQ

When did Danaher report Q1 2026 earnings?
Danaher (DHR) reported Q1 2026 earnings on April 21, 2026 before market open.
What were Danaher's Q1 2026 revenue and EPS?
Danaher reported revenue of $6.0B and eps of $2.06 for Q1 2026.
Did Danaher beat estimates in Q1 2026?
Revenue missed the consensus estimate of $6.0B by $30.6M. EPS beat the consensus estimate of $1.94 by $0.12.
Where can I find Danaher's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000313616-26-000109) and the 10-Q periodic report (0000313616-26-000107) directly on SEC EDGAR. The filing index links above go to sec.gov.